Utah Medical Products, Inc. (UTMD)
 NASDAQ: UTMD · Real-Time Price · USD
 56.60
 -0.42 (-0.74%)
  At close: Oct 30, 2025, 4:00 PM EDT
56.97
 +0.37 (0.65%)
  After-hours: Oct 30, 2025, 4:30 PM EDT
Utah Medical Products Market Cap
Utah Medical Products has a market cap or net worth of $181.36 million as of October 30, 2025. Its market cap has decreased by -21.59% in one year.
Market Cap 
 181.36M
Enterprise Value 
 97.33M
1-Year Change 
 -21.59%
Ranking 
 Category 
 Stock Price 
$56.60
Market Cap Chart
Since March 8, 1999, Utah Medical Products's market cap has increased from $49.30M to $181.36M, an increase of 267.86%. That is a compound annual growth rate of 5.01%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 182.80M | -12.33% | 
| Dec 31, 2024 | 208.50M | -31.80% | 
| Dec 29, 2023 | 305.70M | -16.18% | 
| Dec 30, 2022 | 364.70M | -0.11% | 
| Dec 31, 2021 | 365.10M | 18.96% | 
| Dec 31, 2020 | 306.90M | -23.56% | 
| Dec 31, 2019 | 401.50M | 29.43% | 
| Dec 31, 2018 | 310.20M | 2.41% | 
| Dec 29, 2017 | 302.90M | 10.71% | 
| Dec 30, 2016 | 273.60M | 24.65% | 
| Dec 31, 2015 | 219.50M | -2.36% | 
| Dec 31, 2014 | 224.80M | 5.15% | 
| Dec 31, 2013 | 213.80M | 60.99% | 
| Dec 31, 2012 | 132.80M | 35.10% | 
| Dec 30, 2011 | 98.30M | 1.13% | 
| Dec 31, 2010 | 97.20M | -8.13% | 
| Dec 31, 2009 | 105.80M | 25.95% | 
| Dec 31, 2008 | 84.00M | -27.84% | 
| Dec 31, 2007 | 116.40M | -10.67% | 
| Dec 29, 2006 | 130.30M | 5.59% | 
| Dec 30, 2005 | 123.40M | 33.55% | 
| Dec 31, 2004 | 92.40M | -23.38% | 
| Dec 31, 2003 | 120.60M | 28.30% | 
| Dec 31, 2002 | 94.00M | 37.43% | 
| Dec 31, 2001 | 68.40M | 81.43% | 
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 736.59B | 
| Johnson & Johnson | 447.12B | 
| AbbVie | 399.03B | 
| UnitedHealth Group | 325.70B | 
| AstraZeneca | 255.54B | 
| Novartis AG | 239.27B | 
| Novo Nordisk | 229.86B | 
| Abbott Laboratories | 217.57B |